CLINICAL_TRIALS
trial_result
· 2023-04-07
Clinical Trial Update: Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED) [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating AD313 with atomoxetine (SEED) for obstructive sleep apnea has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apnimed | Conditions: Obstructive Sleep Apnea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-07